scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00508-015-0930-4 |
P698 | PubMed publication ID | 27052228 |
P50 | author | Markus Kofler | Q43196532 |
P2093 | author name string | Heidemarie Abrahamian | |
Monika Lechleitner | |||
Claudia Francesconi | |||
P2860 | cites work | Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. | Q46126607 |
Oxidative stress and autonomic nerve function in early type 1 diabetes | Q51152548 | ||
The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. | Q53238631 | ||
How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures | Q59562335 | ||
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study | Q69440204 | ||
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study | Q70651014 | ||
Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up | Q71876330 | ||
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy | Q72408304 | ||
The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study | Q72717809 | ||
Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores | Q73062706 | ||
Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients | Q73373288 | ||
Distinctive electrophysiological features of denervated muscle in uremic patients | Q74150680 | ||
Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors | Q74706934 | ||
(9) Microvascular complications and foot care | Q86396540 | ||
Pregabalin for acute and chronic pain in adults | Q24239867 | ||
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the [...] | Q28288249 | ||
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
Experimental diabetic neuropathy: an update | Q33706830 | ||
Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation | Q33870062 | ||
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments | Q34153575 | ||
Diabetic autonomic neuropathy | Q34193010 | ||
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy | Q34218901 | ||
Diabetic neuropathy: clinical manifestations and current treatments | Q34275990 | ||
From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy | Q34439612 | ||
Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes | Q35043229 | ||
Diagnosis and treatment of diabetic autonomic neuropathy | Q35087658 | ||
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial | Q35179957 | ||
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. | Q35225448 | ||
Treatment of diabetic polyneuropathy: Update 2006. | Q36675881 | ||
Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms | Q36806531 | ||
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion | Q37054976 | ||
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy | Q37212329 | ||
Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy | Q37338595 | ||
Impact of pancreas transplantation on type 1 diabetes-related complications | Q37654317 | ||
Diabetic neuropathy: cellular mechanisms as therapeutic targets | Q37930962 | ||
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy | Q37978264 | ||
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy | Q38093664 | ||
Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments | Q40937034 | ||
The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity | Q41116085 | ||
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor | Q43794467 | ||
Treatment of diabetic neuropathy and neuropathic pain: how far have we come? | Q44018868 | ||
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management | Q44369533 | ||
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population | Q44908082 | ||
P304 | page(s) | S73-9 | |
P577 | publication date | 2016-04-01 | |
P1433 | published in | Vienna Clinical Weekly | Q15759796 |
P1476 | title | [Diabetic neuropathy] | |
P478 | volume | 128 Suppl 2 |
Search more.